Cowen and Company’s BiomX Inc. Warrants to purchase one-half of a share of Common Stock PHGE.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-30,759
Closed -$4K 803
2022
Q1
$4K Sell
30,759
-25,244
-45% -$2.98K ﹤0.01% 568
2021
Q4
$6K Buy
+56,003
New +$15.2K ﹤0.01% 601
2020
Q1
Sell
-21,700
Closed -$10K 558
2019
Q4
$10K Buy
+21,700
New +$13.5K ﹤0.01% 392

Other funds holding PHGE.WS

Cowen and Company's PHGE.WS Position: Q2 2022 in Review

Cowen and Company sold out of BiomX Inc. Warrants to purchase one-half of a share of Common Stock (PHGE.WS) in Q2 2022, closing a stake of 30,759 shares — an estimated $4K sold.

Cowen and Company first reported a position in PHGE.WS in Q4 2019 and held it in 3 quarters. The position peaked at $10K in Q4 2019. 8 funds tracked by Wall St. Rank hold PHGE.WS as of Q2 2022.

  • Cowen and Company reported no remaining BiomX Inc. Warrants to purchase one-half of a share of Common Stock position as of Q2 2022 after selling out during the quarter.
  • Cowen and Company sold 30,759 BiomX Inc. Warrants to purchase one-half of a share of Common Stock shares in Q2 2022, an estimated $4K.
  • Cowen and Company first reported a position in BiomX Inc. Warrants to purchase one-half of a share of Common Stock in Q4 2019 and held it in 3 quarters.
  • Cowen and Company's BiomX Inc. Warrants to purchase one-half of a share of Common Stock position peaked at $10K in Q4 2019.
  • 8 funds tracked by Wall St. Rank held BiomX Inc. Warrants to purchase one-half of a share of Common Stock as of Q2 2022.

Based on Cowen and Company's 13F filing for Q2 2022, filed 5 Aug 2022.